FDA Inspection
Sunrise Pharmaceutical, Inc.Sunrise Pharmaceutical, Inc. – FDA Inspection, Dec 20, 2010
Record Details
This FDA Inspection record concerns Sunrise Pharmaceutical, Inc., with an inspection on December 20, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sunrise Pharmaceutical, Inc.
- Inspection Date
- December 20, 2010
- Product Type
- Drugs
View Company Profile
ID · cfe0eac7-66af-4539-8617-fd955e5ba36b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 702529
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sunrise Pharmaceutical, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 31, 2026 | Not classified | New Jersey District Office | Drug Quality Assurance |
| January 27, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2017 | Not classified | New Jersey District Office | |
| April 6, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sunrise Pharmaceutical, Inc.
- FDA Inspection 1310416 - 2026-03-31
- FDA Inspection 1198356 - 2023-01-27
- FDA Inspection 1038016 - 2018-01-18
- FDA Inspection 1016794 - 2017-06-22
- FDA Inspection 1013086 - 2017-04-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.